Arca
Skip to content
Tools
Tools

Infantile spasms

Drug research and approvals for infantile spasms: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 6 studies of infantile spasms are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, FDA has 3 approved and 11 open orphan designations naming it, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 6
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 3
  • EU medicines: 1

Recruiting now

Newest posted first, of 6 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 3

  • VigabatrinGamma-amino-N-butyrate transaminase inhibitor
  • GanaxoloneGABA-A receptor; anion channel positive allosteric modulator
  • CorticotropinMelanocortin receptor 2 agonist

Phase 3 3

Phase 2 2

Phase 1 or earlier 1

How its trials ended

44 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 16 whose ending is known, 19% met their primary endpoint, 6% missed it and 75% stopped early.

  • Completed, result not reported1432%
  • Ongoing1023%
  • Stopped: other or unclear818%
  • Status unknown49%
  • Met its primary endpoint37%
  • Stopped: enrollment or feasibility25%
  • Stopped: sponsor or business decision25%
  • Missed its primary endpoint12%

FDA orphan designations

Approved first, then open designations, newest first
Jun 17, 2024VigafydeAs monotherapy for the treatment of infantile spasms in pediatric patients 1 month to 2 years of age for whom the potential benefits…Pyros Pharmaceuticals, Inc.Approved
Oct 15, 2010H.P. Acthar GelTo treat infantile spasmsQuestcor Pharmaceuticals, Inc.Approved
Aug 21, 2009SabrilFor infantile spasms (IS) - 1 month to 2 years of age.H. Lundbeck A/SApproved
Oct 27, 2020TricaprilinTreatment of infantile spasms also known as West's syndromeCerecin, Inc.Designated
Nov 1, 2017Vigabatrin and cosyntropinTreatment of infantile spasmsWest Therapeutic Development, LLCDesignated
Aug 2, 2017CosyntropinTreatment of infantile spasms.West Therapeutic Development, LLCDesignated
Mar 20, 20171-(2-chlorophenyl)-1-(S)-hydroxy-2-(S)-carbamoyloxy-propaneTreatment of infantile spasmsBio-Pharm Solutions, Co., Ltd.Designated
Jun 20, 2016Tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine…Treatment of infantile spasmsAnavex Life Sciences Corp.Designated
Jun 13, 2016CannabidiolTreatment of infantile spasmsJazz Pharmaceuticals Research UK LimitedDesignated
Jul 23, 2015CannabidiolTreatment of infantile spasmsBenuvia Operations LLCDesignated
Oct 31, 2012Tetracosactide hexaacetate (beta 1-24-corticotrophin)Treatment of infantile spasmsCerium Pharmaceuticals, Inc.Designated
Mar 16, 2012CarisbamateManagement of patients with infantile spasmsSK Life Science, Inc.Designated
Sep 15, 2010(1S,3S)-3-amino-4-(difluoromethylene)cyclopentanecarboxylic…Treatment of infantile spasmsCatalyst Pharmaceuticals, Inc.Designated
May 25, 1994GanaxoloneTreatment of infantile spasms.Immedica Pharma ABDesignated

Medicines authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Sep 20, 2018KigabeqVigabatrinOrphelia Pharma S.A.S.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.